“Towards Universal Immunity: How a Revolution in Computational Immunology Bioengineering Is Advancing Universal Vaccines, Universal Antivenom, and Resistance-Proof Antibacterials”
Where & When
Zoom Webinar
Wednesday, November 8, 2023, 1:00 to 2:00 PM PT
About the Speaker
Jacob Glanville is a serial entrepreneur, and computational immuno-engineer. He is the Founder and CEO of Centivax, and was previously the Co-Founder and CEO of Distributed Bio, acquired for $104M in 2020 by Charles River Laboratories.
He has developed multiple seminal methods in the fields of high-throughput antibody repertoire sequencing (PNAS 2009), repertoire decoding algorithms (Nature 2017), single-cell TCR receptor & phenotype sequencing (Nature Biotech, 2014), deconstructing genetic variation in the adaptive immune system (Nature Communications 2015, Nature Reports 2016, PNAS 2011, TI 2017), and computationally guided antibody library engineering (JMB 2011, JMB 2013, COSB 2015). He is the inventor of Centivax Universal Vaccine IP, the Centivax bnAb IP portfolio, the CRL SuperHuman discovery library technology, the CRL Tumbler technology, the Twist TAO technology, the Twist GPCR libraries, the Isogenica VHH technology, and the AbCheck AbAccel technology He has been awarded a Gates Foundation Grand Challenge “Ending the Pandemic Threat,” a National Institute of Health Principle Investigator for an NIH SBIR, a recipient of the 2021 Medical Technology Enterprise Consortium “Prototype of the Year Award” for “Technology Development with Outstanding Progress and High Military Need,” Stanford University Scientific Advisory Committee member for the Sean Parker Center for Allergy and Asthma Research, a Scientific Advisory Board member for the University of San Francisco's Biotechnology program, an affiliate professor of University of San Carlos, a repeat Gates Foundation/Stanford University Computational and Systems Immunology Grant Recipient while a PhD Candidate with Mark Davis at Stanford, a Recipient of Pfizer Achievement award 2010 while Principal Scientist at Pfizer, and has been a course-founding instructor and guest lecturer for multiple graduate-level applied computational and systems immunology courses at Stanford and UCSF.